Matthias Alder, EVP, Business Dev. & Licensing at Sucampo Pharmaceuticals, holds 21.14K shares in Gain Therapeutics (Ticker: GANX), holds 936.00 shares in Sucampo Pharmaceuticals (Ticker: SCMP).

See the Hottest Stocks Based on Insider Trading >

Matthias Alder
Sucampo Pharmaceuticals (SCMP)
EVP, Business Dev. & Licensing

Ranked #46,395 out of 98,624 Corporate Insiders

Profitable Transactions

1 out of 2 Profitable Transactions

Average Return

+4.90%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

GANX

A breakdown of Matthias Alder's holdings

See the Top Stocks by Insiders

Insider Roles

Gain Therapeutics
(GANX)

CEO, Director

Roles that Matthias Alder holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Sucampo Pharmaceuticals
(SCMP)

Rating:Informative Sell

Date:Nov 28, 2016 - Nov 28, 2017

Return:+29.10%

The most profitable trade made by Matthias Alder

See the Latest Stocks Traded by Insiders

Matthias Alder's Trading History

SCMP

Sucampo Pharmaceuticals

Jul 07, 2017

―

Uninformative Buy

6.01K

$16.85K

GANX

Gain Therapeutics

Mar 28, 2024

CEO, Director

Uninformative Buy

24.71K

$62.79K

List of latest transactions for each holding click on a transaction to see Matthias Alder's performance on stock

See All Insider Trading from Today

Matthias Alder insider profile FAQ

What is the percentage of profitable transactions made by Matthias Alder?

The percentage of profitable transactions made by Matthias Alder is 50%.

What is the average return per transaction made by Matthias Alder?

The average return per transaction made by Matthias Alder is 4.90%.

What stocks does Matthias Alder hold?

Matthias Alder holds: SCMP, GANX stocks.

What was Matthias Alder’s latest transaction?

Matthias Alder latest transaction was an Uninformative Buy of $24.71K.

What was Matthias Alder's most profitable transaction?

Matthias Alder’s most profitable transaction was an Informative Sell of SCMP stock on November 28, 2016. The return on the trade was 29.10%.

What is Matthias Alder's role in Sucampo Pharmaceuticals?

Matthias Alder's role in Sucampo Pharmaceuticals is EVP, Business Dev. & Licensing.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Matthias Alder Insider Profile

Matthias Alder Sucampo Pharmaceuticals (SCMP)EVP, Business Dev. & Licensing